AI-enabled Clinical Platform for
Rheumatoid Arthritis Management

iphone-mockup-featuring-a-macbook-air-and-a-small-cactus-m16678-r-el2.png

Problem

Rheumatoid Arthritis (RA) is an inflammatory, chronic disease with devastating social, humanitarian, and economic costs. Modern care system demonstrates limited efficacy, out-of-capacity (there is a growing deficit of rheumatologists in the US that is expected to reach 2x by 2030), and misses on the potential of digital, data-driven methods.

~$100B

Direct and indirect annual cost (in the US and EU)

70%

Higher death hazards compared to that of general population

75%

Of patients are women

>20%

of patients do not achieve

Advancing precision medicine in rheumatology using data

HopeX develops a Clinical Platform for AI-enabled RA Disease Management. The platform collects versatile patient data assets, applies math to generate unique and personalized clinical insights, and delivers integrated services to patients and providers.

HopeX suite of services consists of virtual companion app for patients; remote patient monitoring and clinical decision support tools for providers. By collecting and processing large amount of clinical and RWE patient data we aspire to advance precision medicine in the rheumatology space.

Providers

Patients